1. EachPod

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives - Podcast

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology.

Please direct podcast-related inquiries to [email protected].



Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.

Health & Fitness Technology Tech News Science Medicine
Update frequency
every 5 days
Average duration
21 minutes
Episodes
160
Years Active
2020 - 2025
Share to:
Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor

Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor

Welcome to this special edition of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosted by Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education an…
00:18:24  |   Mon 16 Dec 2024
Celebrating 25 Years of CGM, with Irl Hirsch, MD

Celebrating 25 Years of CGM, with Irl Hirsch, MD

Video Version only on HCPLive!

In celebration of the podcast surpassing 100 episodes, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Te…
00:36:02  |   Sun 15 Dec 2024
News and Updates in Diabetes at AHA 2024

News and Updates in Diabetes at AHA 2024

In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cle…
00:23:05  |   Thu 21 Nov 2024
Tirzepatide’s Long-Term Obesity Data

Tirzepatide’s Long-Term Obesity Data

In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cle…
00:11:45  |   Thu 14 Nov 2024
Latest Updates on Semaglutide

Latest Updates on Semaglutide

Launched on November 14, 2024 to celebrate World Diabetes Day, this episode tackles a flurry of recent news and updates related to semaglutide (Ozempic/Wegovy/Rybelsus), including Novo Nordisk declar…
00:24:32  |   Thu 14 Nov 2024
Diabetes Tech Updates in October 2024

Diabetes Tech Updates in October 2024

This episode spotlights news in diabetes technology from the latter half of October 2024. In the episode, hosts breakdown updates from multiple companies related to continuous glucose monitoring and …
00:18:56  |   Mon 11 Nov 2024
What to Know About the Eversense 365 CGM, with Brian Hansen

What to Know About the Eversense 365 CGM, with Brian Hansen

On September 17, 2024, Ascensia Diabetes Care and Senseonics announced the US Food and Drug Administration's (FDA) clearance of the Eversense 365 system for people with type 1 and type 2 diabetes age…
00:34:08  |   Wed 16 Oct 2024
Lingo Availability & Embecta's Tubeless Patch Pump

Lingo Availability & Embecta's Tubeless Patch Pump

In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabet…
00:11:48  |   Wed 11 Sep 2024
Real-World Experience with Dexcom Stelo

Real-World Experience with Dexcom Stelo

In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into their experience with the Dexc…
00:11:34  |   Wed 11 Sep 2024
Sotagliflozin for T1D and Other ADCES Highlights

Sotagliflozin for T1D and Other ADCES Highlights

This episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, our second related to the Association of Diabetes Care and Education Specialists (ADCES) 2024 annual meeting, s…
00:20:58  |   Wed 21 Aug 2024
First 10 Prices Announced from CMS Price Negotiations

First 10 Prices Announced from CMS Price Negotiations

On August 15, 2024, the Biden-Harris Administration announced the price list for the first 10 drugs selected as part of the Medicare price negotiations between the United States Department of Health …
00:07:57  |   Mon 19 Aug 2024
Navigating ADCES 2024

Navigating ADCES 2024

The Association of Diabetes Care and Education Specialists (ADCES) is an organization ahead of its time in the world of healthcare. Often, those in medicine find the field to be reactionary instead o…
00:25:15  |   Mon 19 Aug 2024
SUMMIT and FINEARTS-HF, with Muthiah Vaduganathan, MD, MPH

SUMMIT and FINEARTS-HF, with Muthiah Vaduganathan, MD, MPH

In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP,  welcome Muthiah Vaduganathan, MD, MPH, cardiologist and codirector of the Center for Cardiometabolic Implementation Science at …
00:22:41  |   Sat 10 Aug 2024
Simplera CGM and Medtronic's Partnership with Abbott

Simplera CGM and Medtronic's Partnership with Abbott

In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes…
00:14:20  |   Sat 10 Aug 2024
CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD

CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD

Even with the second half of the trial yet to be completed, results of the CATALYST trial have initiated a potentially seismic shift in discussions around the management of type 2 diabetes.
With the …
00:23:55  |   Fri 02 Aug 2024
New Early-Stage T1D Monitoring Guidance, with Anastasia Albanese-O'Neill, PhD, APRN

New Early-Stage T1D Monitoring Guidance, with Anastasia Albanese-O'Neill, PhD, APRN

Less than a month after rebranding from JDRF to Breakthrough T1D, the leading type 1 diabetes advocacy organization has now released new consensus guidance related to the monitoring of early-stage ty…
00:21:23  |   Thu 18 Jul 2024
INHALE-3 and Diabetes Tech Updates, with Grazia Aleppo, MD

INHALE-3 and Diabetes Tech Updates, with Grazia Aleppo, MD

At the 84th American Diabetes Association (ADA) Scientific Sessions, INHALE-3 was among the trials to take center stage.
A phase 4 trial comparing the use of inhaled insulin (Afrezza) against standar…
00:24:58  |   Thu 18 Jul 2024
Blue Circle Health, with Monica Gomberg, MD

Blue Circle Health, with Monica Gomberg, MD

Despite being a chronic autoimmune disease, the burden of type 1 diabetes is often overlooked in public health discussions. Not only are patients with type 1 diabetes being tasked with understanding …
00:18:16  |   Thu 18 Jul 2024
Advances in AID and CGM at ADA 2024, with Davida Kruger, NP

Advances in AID and CGM at ADA 2024, with Davida Kruger, NP

In this special edition episode from the 84th American Diabetes Association Scientific Sessions, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, are joined by Davida Kruger, NP, a certified nur…
00:23:48  |   Thu 18 Jul 2024
ADA Introduces Obesity Association, with Robert Gabbay, MD, PhD

ADA Introduces Obesity Association, with Robert Gabbay, MD, PhD

On the opening day of the 84th American Diabetes Association Scientific Sessions, the ADA ushered in a new era for their organization with the announcement of the formation of the Obesity Association…
00:12:04  |   Thu 18 Jul 2024
Disclaimer: The podcast and artwork embedded on this page are the property of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives. This content is not affiliated with or endorsed by eachpod.com.